Adocia ADR
Stock Exchange Other OTC
EPS
-
Market Cap
-
Shares Outstanding
6.92 M
Public Float
-
Adocia
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
6.92 M
Public Float
-
Adocia
Stock Exchange Euronext Paris
EPS
EUR0.96
Market Cap
EUR131.08 M
Shares Outstanding
6.92 M
Public Float
3.91 M

Profile

Address
115 avenue Lacassagne
Lyon Rhone-Alpes 69003
France
Employees -
Website http://www.adocia.com
Updated 07/08/2019
Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. Its product pipelines include: BioChaperone Lispro; BioChaperone Combo; HinsBet; BioChaperone Human Glucagon; BioChaperone Glargine GLP-1; and BioChaperone Prandaial Combinations for T1D. The company was founded by Gérard, Olivier, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.

Financials

View All
Created with Highcharts 5.0.14AdociaNet Income. Fiscal year is January-December. All values EUR Thousands.4 2934 29320 71520 71512 55312 5537 8927 8928 5508 5507 6157 61520132014201520162017201805k10k15k20k25k
Created with Highcharts 5.0.14AdociaSales/Revenue. Fiscal year is January-December. All values EUR Thousands.5 5885 58870470436 93636 93622 48822 48819 46919 46947 38947 389201320142015201620172018010k20k30k40k50k

Gérard Soula
Chairman & Chief Executive Officer
Olivier Soula
Director, Director-R&D, Deputy CEO